Navigation Links
Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
Date:12/13/2011

SAN DIEGO, Dec. 13, 2011 /PRNewswire/ -- Astellas Pharma Inc. (Tokyo: 4503, Astellas) and Ambit Biosciences Corporation announced today that updated results from an interim analysis of a Phase 2 study of quizartinib (formerly AC220) in acute myeloid leukemia (AML) were presented at the 53rd Annual Meeting of the American Society of Hematology (ASH) in San Diego, California.  Data were also presented from two additional posters: one evaluating the pharmacodynamic effects of quizartinib in a pooled analysis from Phase 1 and Phase 2 studies, and another demonstrating that quizartinib enhances the activity of chemotherapy in an in vivo preclinical model of AML harboring the FLT3-ITD mutation.  The findings from those presentations are described below.

"AML is amongst the most challenging hematological malignancies to treat, and very few treatment advances have been made in several decades," said Jorge Cortes, M.D., Internist and Professor, Deputy Chair, Department of Leukemia, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and primary investigator for the Phase 2 Study.  "A significant portion of AML patients have activating FLT3 mutations, and these patients have a particularly poor prognosis and often relapse or are refractory to current treatment options.  These clinical and preclinical results with quizartinib in FLT3-ITD positive AML are encouraging, and support conduct of further studies of this promising compound both as a monotherapy and in combination with other treatments."

A Phase 2 Open-Label, AC220 Monotherapy Efficacy Study in Patients with Refractory/Relapsed FLT3-ITD Positive Acute Myeloid Leukemia:  Updated Interim Results

The updated clinical response and safety data are from a planned interim analysis of a 62 patient subset from the ongoing Phase 2 multi-center study being conducted in the United States and Europe. Pat
'/>"/>

SOURCE Ambit Biosciences
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. Ambit Biosciences Announces Transition in Company Leadership
3. Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia
4. Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
5. Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back
6. Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients
7. CV Therapeutics Board of Directors Rejects Astellas Tender Offer
8. CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas Tender Offer
9. CV Therapeutics Board of Directors Rejects Astellas Unsolicited Proposal
10. CV Therapeutics Statement on Unsolicited Proposal From Astellas
11. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... New programme aims to ... pharmaceutical and chemical sectors Pfizer Asia ... and Siemens Pte. Ltd, have signed on as ... Programme - Innovative Processing of Specialties and Pharmaceuticals ... Engineering Sciences (ICES), the consortium offers a platform ...
(Date:6/19/2013)... 2013 For an eco-friendly selection for ... Baths using metallic beads instead of water. The ... not require germicides. Yet, the bead bath delivers exceptional ... is always ready unlike a water bath, no warm-up ... bath, which eliminates the contamination and maintenance issues related ...
(Date:6/19/2013)... June 19, 2013 Bellevue city ... hall of technology solutions for people with disabilities ... Hyatt Regency Bellevue. , The exhibit hall, ... on Saturday and Sunday, will feature leading manufacturers ... wheelchairs, communication devices, eyegaze technologies, computer applications, and ...
(Date:6/19/2013)... June 19, 2013 An article posted earlier ... the increasing number of uses for probiotics. The article stated ... and the associate benefits may beeb listed, the actual ... and helping clear skin conditions. While the total uses of ... on the the uses of these “miracle” bacterium, and debunked ...
Breaking Biology Technology:Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 2Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 3Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 4Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths 2City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall 2Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health 2
... QUINCY, Mass., July 18 BioEnergy International, ... of,next-generation, renewable biochemicals and biofuels, announces the,acquisition ... (OBI) and the,integration of its current employees. ... competencies and proprietary Bacillus host technology,and metabolic ...
... on Insulin Sensitization Poster Wins One ... ... Bioscience, Inc.,leaders in real-time measurement of cellular bioenergetics announced today,the receipt ... at the 16th European Congress on Obesity (ECO 2008) May 14-17,2008 ...
... there to see inside a magnet that,s smaller than the head ... invented a new kind of MRI technique to do just that. ... computers, and even give doctors a new tool for studying the ... as heart disease. , In a recent issue of Physical ...
Cached Biology Technology:BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc. 2BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc. 3Seahorse Bioscience Receives Poster Award from the European Association for the Study of Obesity 2New kind of MRI enables study of magnets for computer memory 2New kind of MRI enables study of magnets for computer memory 3
(Date:6/19/2013)... of the patients who received injections of steroids ... New England Compounding Center has found that some ... not experience a worsening of their symptoms and ... infection, especially among those individuals who received injections ... along with an editorial by UC Davis Assistant ...
(Date:6/19/2013)... 19, 2013 - The Flemish plant scientist Marc Van ... Prize 2013", jointly with the American scientists Mary-Dell Chilton ... DC on Wednesday by the US Secretary of State, ... Prize for food and agriculture" - gives the award ... been of exceptional social importance for the quality, quantity ...
(Date:6/19/2013)... researchers at the University of Pittsburgh has developed ... HIV, that could be potential treatments for drug-resistant ... These new agents are quite small, making them ... published in the June 2013 issue of the ... The first of many probable applications will likely ...
Breaking Biology News(10 mins):Evolution of an outbreak: Complications from contaminated steroid injections 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 3World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 4HIV-derived antibacterial shows promise against drug-resistant bacteria 2
... Hall of Fame awards will be presented on April 3 ... Memorial Hall of Fame, established in 1981, serves as a ... or other individual who has been an active member of ... medicine. This year,s awards will honor Fred Winsberg, MD, Martin ...
... across the nation revamped curricula to meet requirements of ... for children to be physically active during the school ... better served by taking into account findings from a ... physical education classes, recess periods and after-school exercise programs. ...
... National Institute of Standards and Technology (NIST) and ... manufacturing integrated circuits at the nanometer (billionth of ... a method for engineering the first-ever nanoscale fluidic ... As described in a paper published online today ...
Cached Biology News:AIUM presents 2009 Memorial Hall of Fame awards 2Physical activity may strengthen children's ability to pay attention 2Physical activity may strengthen children's ability to pay attention 3Physical activity may strengthen children's ability to pay attention 4NIST-Cornell team builds world's first nanofluidic device with complex 3-D surfaces 2NIST-Cornell team builds world's first nanofluidic device with complex 3-D surfaces 3NIST-Cornell team builds world's first nanofluidic device with complex 3-D surfaces 4
...
... clone 41D GenBank Accession Number ... clusterin purified from human serum Formulation: ... and 0.05% sodium azide Quality Assurance: ... HeLa cells or MCF-7 cell lysates. ...
Anti-CoralHue Dronpa Green Monoclonal Antibody Research Focus: cell surface antigens Storage: -20C Shipping Temperature: +4C...
Sheep polyclonal to Methaqualone ( Abpromise for all tested applications). Antigen: Methaqualone(5') conjugated to BSA...
Biology Products: